Scarica l'app Stockscreener
4.31
2.49%
-0.11
Dopo l'orario di chiusura:
4.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FHTX Giù?
Forum
Previsione
Precedente Chiudi:
$4.42
Aprire:
$4.5
Volume 24 ore:
222.46K
Relative Volume:
1.84
Capitalizzazione di mercato:
$243.64M
Reddito:
$34.16M
Utile/perdita netta:
$-98.43M
Rapporto P/E:
-1.8419
EPS:
-2.34
Flusso di cassa netto:
$-119.33M
1 W Prestazione:
-2.49%
1M Prestazione:
-12.04%
6M Prestazione:
+24.21%
1 anno Prestazione:
-46.86%
Intervallo 1D:
$4.30
$4.57
Intervallo di 1 settimana:
$4.0207
$4.57
Portata 52W:
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Nome
Foghorn Therapeutics Inc
Settore
Industria
Telefono
617-586-3100
Indirizzo
500 TECHNOLOGY SQUARE, CAMBRIDGE
Confronta FHTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.31 | 245.91M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Ripresa | B. Riley Securities | Buy |
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Iniziato | B. Riley Securities | Buy |
| 2024-09-03 | Iniziato | Jefferies | Buy |
| 2024-08-19 | Iniziato | Evercore ISI | Outperform |
| 2023-03-28 | Iniziato | BofA Securities | Buy |
| 2023-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2021-11-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-17 | Iniziato | Cowen | Outperform |
| 2020-11-17 | Iniziato | Goldman | Buy |
| 2020-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-17 | Iniziato | Wedbush | Outperform |
Mostra tutto
Foghorn Therapeutics Inc Borsa (FHTX) Ultime notizie
Why Foghorn Therapeutics Inc. stock is rated strong buyOil Prices & Free Technical Confirmation Trade Alerts - newser.com
Visualizing Foghorn Therapeutics Inc. stock with heatmapsJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Foghorn Therapeutics (FHTX) Unveils Key Developments in ARID1B D - GuruFocus
Foghorn Therapeutics Announces Development Updates for Selective ARID1B Degrader Program and Upcoming Investor Event - Quiver Quantitative
Foghorn Therapeutics Announces Significant Progress for - GlobeNewswire
Oct 29 Keynote: Foghorn's Selective ARID1B Degrader Shows Significant Progress; Investor Event Oct 30 - Stock Titan
What does recent volatility data suggest for Foghorn Therapeutics Inc.Forecast Cut & High Accuracy Trade Alerts - newser.com
Using R and stats models for Foghorn Therapeutics Inc. forecasting2025 Institutional Moves & Risk Controlled Swing Trade Alerts - newser.com
Foghorn Therapeutics Inc. stock daily chart insightsJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Analysts Set Foghorn Therapeutics Inc. (NASDAQ:FHTX) Target Price at $11.00 - Defense World
Has Foghorn Therapeutics Inc. formed a bullish divergenceMarket Growth Report & Smart Allocation Stock Tips - newser.com
Using Python tools to backtest Foghorn Therapeutics Inc. strategies2025 Top Gainers & High Win Rate Trade Tips - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.July 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
What institutional flow reveals about Foghorn Therapeutics Inc.Weekly Gains Report & Weekly Return Optimization Alerts - newser.com
Multi asset correlation models including Foghorn Therapeutics Inc.2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Will Foghorn Therapeutics Inc. stock go up soonQuarterly Profit Review & Long-Term Capital Growth Strategies - newser.com
Published on: 2025-10-09 05:14:43 - newser.com
Foghorn Therapeutics (NASDAQ:FHTX) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why Foghorn Therapeutics Inc. stock is seen as undervaluedEntry Point & Safe Entry Zone Tips - newser.com
Using Ichimoku Cloud for Foghorn Therapeutics Inc. technicalsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Chart based exit strategy for Foghorn Therapeutics Inc.Market Risk Report & Verified Technical Trade Signals - newser.com
Detecting price anomalies in Foghorn Therapeutics Inc. with AIOil Prices & Free Technical Pattern Based Buy Signals - newser.com
How to monitor Foghorn Therapeutics Inc. with trend dashboardsMarket Performance Recap & Consistent Profit Alerts - newser.com
Foghorn Therapeutics Inc Azioni (FHTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):